Category: Legislative

The U.S. Congressional Budget Office (CBO) estimates that eliminating the limit on rebates that drug manufacturers pay to Medicaid, now capped at 100 percent of a drug’s average manufacturer price (AMP), “would reduce direct spending in Medicaid by $15.9 billion

The U.S. House Energy and Commerce Committee on Friday passed pandemic-relief legislation with language that could cause pharmaceutical manufacturers to owe states Medicaid drug rebates worth more than a drug’s average manufacturer price (AMP). It could also result in additional

As expected, U.S. Sen. Richard Burr (R-N.C.) on Tuesday was formally named the highest-ranking Republican member of the Senate Health, Education, Labor, and Pensions (HELP) committee, the Senate committee with jurisdiction over the 340B program.

“As Ranking Member of the

U.S. Reps. Peter Welch (D-Vt.) and David McKinley (R-W.Va.) have reintroduced bipartisan legislation in the U.S. House to give 340B rural and free-standing cancer hospitals access to 340B pricing on orphan drugs—which according to a 2019 study are 25

A second Republican 340B-related amendment, regarding what covered entities could charge patients for insulin, was offered and then tabled in the U.S. Senate late last week to a budget bill linked to Democrats’ forthcoming COVID-19 relief package.

Sen. Kevin Cramer’s